Greenstar Biosciences Corp.

CNSX: GSTR


Canadian symbol: GSTR.CN
US symbol: GTSIF

Currency in CAD

Valuation Measures

Market Cap (intraday) 56.67M
Enterprise Value 37.03M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.58
Price/Book (mrq)1.20
Enterprise Value/Revenue 37.99
Enterprise Value/EBITDA 6-2.78

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-36.36%
S&P500 52-Week Change 314.65%
52 Week High 30.1850
52 Week Low 30.0000
50-Day Moving Average 30.0781
200-Day Moving Average 30.0609

Share Statistics

Avg Vol (3 month) 3405.38k
Avg Vol (10 day) 31.3M
Shares Outstanding 566.71M
Float 48.78M
% Held by Insiders 10.06%
% Held by Institutions 10.00%
Shares Short (Jul. 14, 2020) 411.01k
Short Ratio (Jul. 14, 2020) 40
Short % of Float (Jul. 14, 2020) 4N/A
Short % of Shares Outstanding (Jul. 14, 2020) 40.00%
Shares Short (prior month Jun. 14, 2020) 412.34k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:2
Last Split Date 3May 29, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Aug. 30, 2019
Most Recent Quarter (mrq)May 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-330.25%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)880.38k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)29.00%
Gross Profit (ttm)550.27k
EBITDA -2.53M
Net Income Avi to Common (ttm)-2.94M
Diluted EPS (ttm)-0.0450
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.29k
Total Cash Per Share (mrq)0
Total Debt (mrq)407.64k
Total Debt/Equity (mrq)7.39
Current Ratio (mrq)2.42
Book Value Per Share (mrq)0.08

Cash Flow Statement

Operating Cash Flow (ttm)-1.57M
Levered Free Cash Flow (ttm)N/A

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
GSTR.CN
Greenstar Biosciences
5 months ago
GSTR.CN
Greenstar Biosciences
5 months ago
GSTR.CN
Greenstar Biosciences
7 months ago
GSTR.CN
Greenstar Biosciences
7 months ago
GSTR.CN
Greenstar Biosciences
7 months ago
GSTR.CN
Greenstar Biosciences
8 months ago
GSTR.CN
Greenstar Biosciences
8 months ago
GSTR.CN
Greenstar Biosciences
8 months ago
GSTR.CN
Greenstar Biosciences
8 months ago
GSTR.CN
Greenstar Biosciences
8 months ago
GSTR.CN
Greenstar Biosciences
8 months ago
GSTR.CN
Greenstar Biosciences
8 months ago
GSTR.CN
Greenstar Biosciences
8 months ago
GSTR.CN
Greenstar Biosciences
8 months ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
0.06%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Greenstar Biosciences Corp.


GreenStar Biosciences' Partner Cowlitz Reports Revenues for Q1 2020

GreenStar Biosciences’ Partner Cowlitz Reports Revenues for Q1 2020

Vancouver, British Columbia--(Newsfile Corp. - July 29, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has generated over US$6.58 million in gross sales revenues for the three months ended March 31, 2020, r... Read More...
GreenStar Biosciences Completes Acquisition of 100% of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer

GreenStar Biosciences Completes Acquisition of 100% of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer

Strategic acquisition by GreenStar adds innovative company focused on the development of effective therapeutics using psychedelic medicineVancouver, British Columbia--(Newsfile Corp. - July 27, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce, further to its press rele... Read More...
GreenStar Biosciences Announces Closing of Private Placement and Debt Settlement

GreenStar Biosciences Announces Closing of Private Placement and Debt Settlement

Vancouver, British Columbia--(Newsfile Corp. - July 23, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it has closed a non-brokered private placement of common shares for gross proceeds of $585,000 (the "Offering"). The Offering consisted of the issuance of an ... Read More...
GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

Strategic acquisition by GreenStar to add innovative company focused on the development of effective therapeutics using psychedelic medicineVancouver, British Columbia--(Newsfile Corp. - July 21, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce, further to its press re... Read More...
GreenStar Biosciences Announces Non-Brokered Private Placement and Debt Settlement

GreenStar Biosciences Announces Non-Brokered Private Placement and Debt Settlement

Vancouver, British Columbia--(Newsfile Corp. - July 20, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it will proceed with a non-brokered private placement of common shares to raise gross proceeds of up to $585,000 (the "Offering"). The Offering will consist o... Read More...
Greenstar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.

Greenstar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.

Strategic acquisition by GreenStar to add innovative company focused on the development of effective therapeutics using psychedelic medicineVancouver, British Columbia--(Newsfile Corp. - June 16, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it has signed a no... Read More...
GreenStar Biosciences Announces Stock Option Issuance and Cancellation of Stock Options

GreenStar Biosciences Announces Stock Option Issuance and Cancellation of Stock Options

Vancouver, British Columbia--(Newsfile Corp. - May 25, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar"), announces it has granted stock options to acquire a total of 200,000 common shares of the Company to a director of the Company. The options are exercisable at a price of $0.14 per share and expire three years from the date... Read More...
GreenStar Biosciences' Cowlitz Reports Record Breaking Revenues of US$19.5 M for 2019

GreenStar Biosciences’ Cowlitz Reports Record Breaking Revenues of US$19.5 M for 2019

Vancouver, British Columbia--(Newsfile Corp. - March 2, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has generated over US$19.5 million in gross sales revenues for 2019."We are very pleased with the rate at which Cowlitz i... Read More...
GreenStar Biosciences Announces Grants and Cancellation of Stock Options

GreenStar Biosciences Announces Grants and Cancellation of Stock Options

Vancouver, British Columbia--(Newsfile Corp. - February 7, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), announces it has granted stock options to acquire a total of 3,378,836 common shares of the Company to certain officers and consultants of the Company. The options are exercisable at ... Read More...
Greenstar Biosciences Announces M&A Focussed Strategic Additions to Its Executive Team and Corporate Update

Greenstar Biosciences Announces M&A Focussed Strategic Additions to Its Executive Team and Corporate Update

Vancouver, British Columbia--(Newsfile Corp. - December 6, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), announces that it has engaged Invictus Accounting Group LLP ("Invictus") to provide CFO and strategic advisory services to the Company.Mr. Brian Zasitko has been appointed the Company... Read More...
GreenStar Biosciences Announces Transformational Phase One Expansion at Cowlitz

GreenStar Biosciences Announces Transformational Phase One Expansion at Cowlitz

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has completed the first phase of its expansion initiatives with the completion of several grow rooms... Read More...
GreenStar Biosciences' Cowlitz Generates US$11.8M in First Seven Months of 2019

GreenStar Biosciences' Cowlitz Generates US$11.8M in First Seven Months of 2019

Vancouver, British Columbia--(Newsfile Corp. - October 1, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has generated more than US$11.87 million in gross sales revenues during the first seven months to July 31, 2019."We are... Read More...
Greenstar Biosciences Announces Successful Testing Results Using Proprietary Grow Technology

Greenstar Biosciences Announces Successful Testing Results Using Proprietary Grow Technology

Vancouver, British Columbia--(Newsfile Corp. - September 11, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), a growth-oriented technology and services company that provides real estate, financial, management and other support to licensed cannabis businesses in the United States, is pleased to announce that ... Read More...
GreenStar Biosciences Retains Integral Wealth Securities Ltd. for Market Making

GreenStar Biosciences Retains Integral Wealth Securities Ltd. for Market Making

Vancouver, British Columbia--(Newsfile Corp. - August 8, 2019) - GreenStar Biosciences Corp. (CSE: GSTR) ("GreenStar" or the "Company"), a growth-oriented technology and services company that provides real estate, financial, management and other support to licensed cannabis businesses in the United States, is pleased to announce that it h... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
GSTR.CD
Canadian Securities Exchange - CSE Listed
Canadian Securities Exchange - CSE Listed0.10CAD-4.76%
GTSIF.PK
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.07USD0.00%
GTSIF.PQ
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.06USD-18.99%

Delayed data (1h)
NameAgePositionAppointed
Ralph Olson
President
--President2019
Thomas W. Baird
Chief Executive Officer, Director
55Chief Executive Officer, Director2020
Gavin Cooper
Chief Financial Officer, Director
70Chief Financial Officer, Director2015
Emily Davis
Director
--Director2017
Vince Sorace
Director
--Director2019


Share this page